Pia Baldinger

Pia Baldinger

Auto-generated profile, based on publicly available information

Pia Baldinger

Medical University of Vienna

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2013 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
RSRonald Sladky
Ronald Sladky
AHAnna Höflich
Anna Höflich
MKMartin Küblböck
Martin Küblböck
CKChristoph Kraus
Christoph Kraus
PBPia Baldinger
Pia Baldinger
Christian WindischbergerChristian Windischberger
Christian Windischberger
Social anxiety disorder (SAD) is characterized by over-reactivity of fear-related circuits in social or performance situations and associated with marked social impairment. We used dynamic causal modeling (DCM), a method to evaluate effective connectivity, to test our hypothesis that SAD patients would exhibit dysfunctions in the amygdala–prefrontal emotion regulation network. Thirteen unmedicated SAD patients and 13 matched healthy controls performed a series of facial emotion and object discrimination tasks while undergoing fMRI. The emotion-processing network was identified by a task-related contrast and motivated the selection of the right amygdala, OFC, and DLPFC for DCM analysis. Bayesian model averaging for DCM revealed abnormal connectivity between the OFC and the amygdala in SAD patients. In healthy controls, this network represents a negative feedback loop. In patients, however, positive connectivity from OFC to amygdala was observed, indicating an excitatory connection. As we did not observe a group difference of the modulatory influence of the FACE condition on the OFC to amygdala connection, we assume a context-independent reduction of prefrontal control over amygdalar activation in SAD patients. Using DCM, it was possible to highlight not only the neuronal dysfunction of isolated brain regions, but also the dysbalance of a distributed functional network.

30 January 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
AHAndreas Hahn
Andreas Hahn
Wolfgang WadsakWolfgang Wadsak
Wolfgang Wadsak
Christian WindischbergerChristian Windischberger
Christian Windischberger
PBPia Baldinger
Pia Baldinger
AHAnna S. Höflich
Anna S. Höflich
RLRupert Lanzenberger
Rupert Lanzenberger
Reflecting one's mental self is a fundamental process for evaluating the personal relevance of life events and for moral decision making and future envisioning. Although the corresponding network has been receiving growing attention, the driving neurochemical mechanisms of the default mode network (DMN) remain unknown. Here we combined positron emission tomography and functional magnetic resonance imaging to investigate modulations of the DMN via serotonin-1A receptors (5-HT1A), separated for 5-HT autoinhibition (dorsal raphe nucleus) and local inhibition (heteroreceptors in projection areas). Using two independent approaches, regional 5-HT1Abinding consistently predicted DMN activity in the retrosplenial cortex for resting-state functional magnetic resonance imaging and the Tower of London task. On the other hand, both local and autoinhibitory 5-HT1Abinding inversely modulated the posterior cingulate cortex, the strongest hub in the resting human brain. In the frontal part of the DMN, a negative association was found between the dorsal medial prefrontal cortex and local 5-HT1Ainhibition. Our results indicate a modulation of key areas involved in self-referential processing by serotonergic neurotransmission, whereas variations in 5-HT1Abinding explained a considerable amount of the individual variability in the DMN. Moreover, the brain regions associated with distinct introspective functions seem to be specifically regulated by the different 5-HT1Abinding sites. Together with previously reported modulations of dopamine and GABA, this regional specialization suggests complex interactions of several neurotransmitters driving the default mode network.

3 July 2012 in Molecular Psychiatry
Verified
Journal Article
Open access
RLRupert Lanzenberger
Rupert Lanzenberger
PBP Baldinger
P Baldinger
AHAndreas Hahn
Andreas Hahn
JUJ Ungersboeck
J Ungersboeck
Markus MitterhauserMarkus Mitterhauser
Markus Mitterhauser
RFR Frey
R Frey
Electroconvulsive therapy (ECT) is a potent therapy in severe treatment-refractory depression. Although commonly applied in psychiatric clinical routine since decades, the exact neurobiological mechanism regarding its efficacy remains unclear. Results from preclinical and clinical studies emphasize a crucial involvement of the serotonin-1A receptor (5-HT1A) in the mode of action of antidepressant treatment. This includes associations between treatment response and changes in 5-HT1A function and density by antidepressants. Further, alterations of the 5-HT1A receptor are consistently reported in depression. To elucidate the effect of ECT on 5-HT1A receptor binding, 12 subjects with severe treatment-resistant major depression underwent three positron emission tomography (PET) measurements using the highly selective radioligand [carbonyl-11C]WAY100635, twice before (test–retest variability) and once after 10.08±2.35 ECT sessions. Ten patients (~83%) were responders to ECT. The voxel-wise comparison of the 5-HT1A receptor binding (BPND) before and after ECT revealed a widespread reduction in cortical and subcortical regions (P<0.05 corrected), except for the occipital cortex and the cerebellum. Strongest reductions were found in regions consistently reported to be altered in major depression and involved in emotion regulation, such as the subgenual part of the anterior cingulate cortex (−27.5%), the orbitofrontal cortex (−30.1%), the amygdala (−31.8%), the hippocampus (−30.6%) and the insula (−28.9%). No significant change was found in the raphe nuclei. There was no significant difference in receptor binding in any region comparing the first two PET scans conducted before ECT. This PET study proposes a global involvement of the postsynaptic 5-HT1A receptor binding in the effect of ECT.

1 June 2014 in The Journal of ECT
Verified
Journal Article
Closed access
PBPia Baldinger
Pia Baldinger
ALAmit Lotan
Amit Lotan
RFRichard Frey
Richard Frey
SKSiegfried Kasper
Siegfried Kasper
BLBernard Lerer
Bernard Lerer
RLRupert Lanzenberger
Rupert Lanzenberger
Electroconvulsive therapy (ECT) is a well-established effective treatment strategy in treatment-refractory depression. However, despite ECT's widespread use, the exact neurobiological mechanisms underlying its efficacy are not fully understood. Over the past 3 decades, extensive work in rodents, primates, and humans has begun to delineate the impact of electroconvulsive seizures (ECS) and ECT on neurotransmission systems commonly implicated in depression. In the current review, we will focus on two major biogenic amine systems, namely serotonin and dopamine. The database of PubMed was searched for preclinical studies describing the effects of ECS on the serotonergic and dopaminergic system using behavioral sensitization paradigms, in vivo brain microdialysis, messenger RNA and protein expression, electrophysiology, and positron emission tomography. Additionally, human data describing ECT's effects on neurotransmitter turnover, receptor binding, and functional imaging were reviewed together with relevant genetic association studies. Literature research resulted in 40 published original studies related to ECS/ECT and the serotonergic system, whereby only three were studies in humans. Regarding dopamine, 15 preclinical and 12 human studies were found in PubMed database. Converging data obtained from genetic and imaging studies in humans have corroborated many of the earlier preclinical and clinical findings relating to enhancement of serotonergic neurotransmission and activation of the mesocorticolimbic dopamine system after ECS/ECT. Moreover, it seems that these effects are evident at various levels, including neurotransmitter release, receptor binding, and overall neurotransmission. Future studies combining convergent modalities could enhance our understanding of the mechanisms underlying ECT's profound antidepressant effect and would support the development of better pharmacological and somatic treatment approaches for refractory depression.

3 January 2017 in The Journal of Clinical Psychiatry
Verified
Journal Article
Closed access
PDF file
AKAlexander Kautzky
Alexander Kautzky
PBPia Baldinger-Melich
Pia Baldinger-Melich
GKGeorg S. Kranz
Georg S. Kranz
TVThomas Vanicek
Thomas Vanicek
DSDaniel Souery
Daniel Souery
SKSiegfried Kasper
Siegfried Kasper
From The Journal of Clinical Psychiatry: Which of your patients with depression are more likely to be treatment-resistant? A European research group looked for possible influences on treatment outcome of 48 clinical, sociodemographic, and psychosocial predictors. See which factors were particularly relevant in predicting treatment resistance.

1 April 2015 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
AKAlexander Kautzky
Alexander Kautzky
PBPia Baldinger
Pia Baldinger
DSDaniel Souery
Daniel Souery
SMStuart Montgomery
Stuart Montgomery
JMJulien Mendlewicz
Julien Mendlewicz
SKSiegfried Kasper
Siegfried Kasper